Chlormadinone acetate in progestin‐primed ovarian stimulation does not negatively affect clinical results

Abstract Purpose To investigate whether progestin‐primed ovarian stimulation (PPOS) with chlormadinone acetate (CMA) adversely affects clinical results and neonatal outcomes, or causes congenital deformities. Methods This retrospective study was conducted at private IVF clinic from November 2018 to...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Sena Shibasaki, Hiromitsu Hattori, Masae Koizumi, Satoko Nagaura, Mayumi Toya, Hideki Igarashi, Koichi Kyono
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2023-01-01
coleção:	Reproductive Medicine and Biology
Assuntos:	chlormadinone acetate congenital abnormality cryopreservation newborn infant ovulation induction
Acesso em linha:	https://doi.org/10.1002/rmb2.12519
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!